T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
T-DM1 与帕妥珠单抗、曲妥珠单抗和紫杉烷类药物作为早期复发 HER2 阳性转移性乳腺癌一线治疗的比较：一项意大利多中心观察性研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100099
Schettini, F; Conte, B; Buono, G; De Placido, P; Parola, S; Griguolo, G; Fabi, A; Bighin, C; Riccardi, F; Cianniello, D; De Laurentiis, M; Puglisi, F; Pelizzari, G; Bonotto, M; Russo, S; Frassoldati, A; Pazzola, A; Montemurro, F; Lambertini, M; Guarneri, V; Cognetti, F; Locci, M; Generali, D; Conte, P; De Placido, S; Giuliano, M; Arpino, G; Del Mastro, L
